PMID- 32149149 OWN - NLM STAT- MEDLINE DCOM- 20201216 LR - 20220413 IS - 2314-6141 (Electronic) IS - 2314-6133 (Print) VI - 2020 DP - 2020 TI - Clinicopathological Analysis of Five Cases of NUT Midline Carcinoma, including One with the Gingiva. PG - 9791208 LID - 10.1155/2020/9791208 [doi] LID - 9791208 AB - AIMS: NUT midline carcinoma (NMC) is a rare, poorly differentiated carcinoma defined by the presence of NUT gene rearrangement. In order to better understand the diagnostic and clinicopathologic features of this disease as they pertain to clinical practice, we have herein compiled findings pertaining to 5 cases of NMC at our institution. METHODS: Clinicopathological findings from 5 NMC cases were retrospectively reviewed, with histologic findings being reassessed and summarized accordingly. Tumor samples in the present study had been stained for markers including NUT, P63, P40, TTF-1, keratin, CK7, Syn, CD56, CgA, CD34, CD117, EGFR, and Ki-67. All cases were subjected to both fluorescence in situ hybridization (FISH) and followed up. RESULTS: Of these 5 NMC cases, 2 were males and 3 were females, with ages ranging from 26 to 69 years. A total of 2 cases localized to the lung, 1 to the larynx, 1 to the maxillary gingiva, and 1 to the orbital cavity. Upon microscopic assessment, these tumors appeared as clusters of small rounded cells with interstitial neutrophil infiltration. Squamous epithelial differentiation varied between samples. NUT staining revealed strong diffuse nuclear staining in tumor cells, and FISH confirmed the presence of NUT gene translocation in these samples. CONCLUSIONS: NMC is a form of highly invasive cancer that can manifest in a number of tissues including the gingiva. NMC tumors have a fairly well-defined pathological morphology, and both immunohistochemistry and FISH are valuable for NMC diagnosis. CI - Copyright (c) 2020 Luting Zhou et al. FAU - Zhou, Luting AU - Zhou L AD - Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. FAU - Yong, Xiang AU - Yong X AD - Department of Pathology, The Third Affiliated Hospital of Bengbu Medical College, Suzhou 234000, China. FAU - Zhou, Jun AU - Zhou J AUID- ORCID: 0000-0002-3823-7615 AD - Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. FAU - Xu, Jiankun AU - Xu J AD - Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. FAU - Wang, Chaofu AU - Wang C AUID- ORCID: 0000-0002-5956-9328 AD - Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. LA - eng PT - Case Reports PT - Journal Article DEP - 20200213 PL - United States TA - Biomed Res Int JT - BioMed research international JID - 101600173 RN - 0 (Antineoplastic Agents) RN - 0 (NUTM1 protein, human) RN - 0 (Neoplasm Proteins) RN - 0 (Nuclear Proteins) SB - IM MH - Adult MH - Aged MH - Antineoplastic Agents/therapeutic use MH - *Carcinoma/diagnosis/drug therapy/genetics/pathology MH - Fatal Outcome MH - Female MH - *Head and Neck Neoplasms/diagnosis/drug therapy/genetics/pathology MH - Humans MH - *Lung Neoplasms/diagnosis/drug therapy/genetics/pathology MH - Male MH - Middle Aged MH - Neoplasm Proteins/genetics MH - Nuclear Proteins/genetics MH - Retrospective Studies PMC - PMC7042505 COIS- The authors declare that there are no conflicts of interest regarding the publication of this paper. EDAT- 2020/03/10 06:00 MHDA- 2020/12/17 06:00 PMCR- 2020/02/13 CRDT- 2020/03/10 06:00 PHST- 2019/10/19 00:00 [received] PHST- 2020/01/27 00:00 [accepted] PHST- 2020/03/10 06:00 [entrez] PHST- 2020/03/10 06:00 [pubmed] PHST- 2020/12/17 06:00 [medline] PHST- 2020/02/13 00:00 [pmc-release] AID - 10.1155/2020/9791208 [doi] PST - epublish SO - Biomed Res Int. 2020 Feb 13;2020:9791208. doi: 10.1155/2020/9791208. eCollection 2020.